Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,226 | -171,961 | -86,331 | -278,482 | -212,659 |
| Depreciation Amortization | 29,042 | 17,567 | 6,620 | 21,641 | 14,730 |
| Accounts receivable | -3,295 | -4,080 | -4,658 | -1,060 | 4,944 |
| Accounts payable and accrued liabilities | 7,468 | 3,311 | -351 | 2,055 | -198 |
| Other Working Capital | -32,576 | -27,681 | -21,079 | 875 | 5,159 |
| Other Operating Activity | -188,961 | 32,430 | 24,682 | 68,680 | 56,373 |
| Operating Cash Flow | $-209,548 | $-150,414 | $-81,117 | $-186,291 | $-131,651 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -96,719 | -28,789 | -9,072 | -3,396 | 28,508 |
| PPE Investments | -643 | -633 | -630 | N/A | -161 |
| Purchase Sale Intangibles | -36,086 | -31,170 | -27,337 | -28,366 | -24,199 |
| Other Investing Activity | 170,088 | -31,170 | -27,337 | -29,157 | -24,199 |
| Investing Cash Flow | $72,726 | $-60,592 | $-37,039 | $-32,553 | $4,148 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 104,926 | 104,926 |
| Common Stock Issued | 219,068 | 218,917 | 218,125 | 24,130 | 23,899 |
| Other Financing Activity | -440 | 345 | -1,129 | -11,483 | -11,803 |
| Financing Cash Flow | $218,628 | $219,262 | $216,996 | $117,573 | $117,022 |
| Exchange Rate Effect | 750 | 930 | 848 | -2,794 | -3,935 |
| Beginning Cash Position | 61,688 | 61,688 | 61,688 | 165,753 | 165,753 |
| End Cash Position | 144,244 | 70,874 | 161,376 | 61,688 | 151,337 |
| Net Cash Flow | $82,556 | $9,186 | $99,688 | $-104,065 | $-14,416 |
| Free Cash Flow | |||||
| Operating Cash Flow | -209,548 | -150,414 | -81,117 | -186,291 | -131,651 |
| Capital Expenditure | -643 | -633 | -630 | N/A | -161 |
| Free Cash Flow | -210,191 | -151,047 | -81,747 | -186,291 | -131,812 |